IVISbrite D-Luciferin Potassium Salt Bio…

The University of Nebraska Medical Center, a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order (PO #4800177033) to Revvity Health Sciences Inc., a vendor based in Chicago, Illinois, for the supply of laboratory reagents. The contract, valued at $1,596.50, covers one unit of IVISbrite D-Luciferin Potassium Salt Bio (material number 122799A-5), a biochemical substrate commonly used in bioluminescence imaging applications. The award was executed on February 5, 2026, with a completion date of February 27, 2026, establishing a 22-day performance period. Delivery is designated to the University of Nebraska Medical Center's Shipping and Receiving department in Omaha, Nebraska, with final unloading at DRC I 7060 Shared Kavita, under Free on Board destination freight prepaid terms.

The purchase order is subject to Net 30 payment terms, with settlement to be made via Nebraska State Treasury warrant. Vendor acknowledgment of the order was required within ten days of issuance. The procurement was processed through the ARIBA Procure-to-Pay system using vendor number 117129 and is governed by the Standard Terms of Purchase established by the University of Nebraska unless superseded by an alternative agreement between Revvity Health Sciences Inc. and the Board of Regents.